Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Clinical research of Yang Yin Fu Zheng Jie Du therapy in HBV related hepatocellular carcinoma
induced anemia. The purpose of this study is to observe the efficacy of routine medical care
combined with Yang Yin Fu Zheng Jie Du therapy for patients belong to HBV-HCC induced anemia.